The Association of Subacute Thyroiditis with COVID-19: a Systematic Review

Hennessey Jv. Subacute thyroiditis. Endotext [Internet]. 2018.

Shrestha RT, Hennessey J. Acute and Subacute, and Riedel’s Thyroiditis. 2015 Dec 8. In: Feingold KR, Anawalt B, Boyce A, Chrousos G, de Herder WW, Dhatariya K, Dungan K, Grossman A, Hershman JM, Hofland J, Kalra S, Kaltsas G, Koch C, Kopp P, Korbonits M, Kovacs CS, Kuohung W, Laferrère B, McGee EA, McLachlan R, Morley JE, New M, Purnell J, Sahay R, Singer F, Stratakis CA, Trence DL, Wilson DP, editors. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000–. PMID: 25905408.

Desailloud R, Hober D. Viruses and thyroiditis: an update. Virol J. 2009;6(1):1–14. https://doi.org/10.1186/1743-422X-6-5.

Scappaticcio L, Pitoia F, Esposito K, Piccardo A, Trimboli P. Impact of COVID-19 on the thyroid gland: an update. Reviews in Endocrine and Metabolic Disorders. 2020 Nov 25:1-3.https://doi.org/10.1007/s11154-020-09615-z

Asfuroglu Kalkan E, Ates I. A case of subacute thyroiditis associated with Covid-19 infection. J Endocrinol Investig. 2020;43:1173–4. https://doi.org/10.1007/s40618-020-01316-3.

Brancatella A, Ricci D, Cappellani D, Viola N, Sgrò D, Santini F, et al. Is subacute thyroiditis an underestimated manifestation of SARS-CoV-2 infection? Insights from a case series. The Journal of Clinical Endocrinology & Metabolism. 2020;105(10):e3742–e6. https://doi.org/10.1210/clinem/dgaa537.

Campos-Barrera E, Alvarez-Cisneros T, Davalos-Fuentes M. Subacute thyroiditis associated with COVID-19. Case reports in endocrinology. 2020;2020:1–4. https://doi.org/10.1155/2020/8891539.

Chakraborty U, Ghosh S, Chandra A, Ray AK. Subacute thyroiditis as a presenting manifestation of COVID-19: a report of an exceedingly rare clinical entity. BMJ Case Reports CP. 2020;13(12):e239953. https://doi.org/10.1136/bcr-2020-239953.

Guven M. Subacute thyroiditis in the course of coronavirus disease 2019: A Case Report. Journal of Endocrinology and Metabolism. 2020;10(3-4):110–2. https://doi.org/10.14740/jem678.

Ippolito S, Dentali F, Tanda M. SARS-CoV-2: a potential trigger for subacute thyroiditis? Insights from a case report. J Endocrinol Investig. 2020;43:1171–2. https://doi.org/10.1007/s40618-020-01312-7.

Khatri A, Charlap E, Kim A. Subacute thyroiditis from COVID-19 infection: a case report and review of literature. European Thyroid Journal. 2020;9(6):309–13.10.1159/000511872.

Maris J, Florencio MQV, Joven MH. Subacute thyroiditis in a patient with coronavirus disease 2019. AACE clinical case reports. 2020;6(6):e361–e4. https://doi.org/10.4158/ACCR-2020-0524.

Mattar SAM, Koh SJQ, Chandran SR, Cherng BPZ. Subacute thyroiditis associated with COVID-19. BMJ Case Reports CP. 2020;13(8):e237336. https://doi.org/10.1136/bcr-2020-237336.

Ruggeri RM, Campennì A, Siracusa M, Frazzetto G, Gullo D. Subacute thyroiditis in a patient infected with SARS-COV-2: an endocrine complication linked to the COVID-19 pandemic. Hormones. 2020;20:1–3. https://doi.org/10.1007/s42000-020-00230-w.

Chong WH, Shkolnik B, Saha B, Beegle S. Subacute thyroiditis in the setting of coronavirus disease 2019. Am J Med Sci. 2020;361:400–2. https://doi.org/10.1016/j.amjms.2020.09.011.

Brancatella A, Ricci D, Viola N, Sgrò D, Santini F, Latrofa F. Subacute thyroiditis after SARS-CoV-2 infection. J Clin Endocrinol Metab. 2020;105(7):2367–70. https://doi.org/10.1210/clinem/dgaa276.

Sohrabpour S, Heidari F, Karimi E, Ansari R, Tajdini A, Heidari F. Subacute thyroiditis in COVID-19 patients. Eur Thyroid J. 2020;9(6):322–4.10.1159/000511707.

Moola S, Munn Z, Tufanaru C, Aromataris E, Sears K, Sfetcu R, Currie M, Lisy K, Qureshi R, Mattis P, Mu P. Chapter 7: Systematic reviews of etiology and risk. In: Aromataris E, Munn Z (Editors). JBI Manual for Evidence Synthesis. JBI, 2020. Available from https://synthesismanual.jbi.global. https://doi.org/10.46658/JBIMES-20-08

Satoh M. Virus-like particles in the follicular epithelium of the thyroid from a patient with subacute thyroiditis (DE QUERVAIN). Pathol Int. 1975 Jul;25(4):499–501. https://doi.org/10.1111/j.1440-1827.1975.tb00868.x.

Prummel MF, Strieder T, Wiersinga WM. The environment and autoimmune thyroid diseases. Eur J Endocrinol. 2004;150(5):605–18. https://doi.org/10.1530/eje.0.1500605.

Nishihara E, Ohye H, Amino N, Takata K, Arishima T, Kudo T, et al. Clinical characteristics of 852 patients with subacute thyroiditis before treatment. Intern Med. 2008;47(8):725–9. https://doi.org/10.2169/internalmedicine.47.0740.

Volpé R. 7 Subacute (de Quervain’s) thyroiditis. Clin Endocrinol Metab. 1979;8(1):81–95. https://doi.org/10.1016/S0300-595X(79)80011-0.

Walfish PG. Thyroiditis. Curr Ther Endocrinol Metab. 1997;6:117–22.

Intenzo CM, Park CH, Kim SM, Capuzzi DM, Cohen SN, Green PA. Clinical, laboratory, and scintigraphic manifestations of subacute and chronic thyroiditis. Clin Nucl Med. 1993;18(4):302–6. https://doi.org/10.1097/00003072-199304000-00007.

Singer PA. Thyroiditis: acute, subacute, and chronic. Med Clin N Am. 1991;75(1):61–77. https://doi.org/10.1016/s0025-7125(16)30472-2.

Alfadda AA, Sallam RM, Elawad GE, AlDhukair H, Alyahya MM. Subacute thyroiditis: clinical presentation and long term outcome. Int J Endocrinol. 2014;2014. https://doi.org/10.1155/2014/794943.

Ruchala M, Szczepanek-Parulska E, Zybek A, Moczko J, Czarnywojtek A, Kaminski G, et al. The role of sonoelastography in acute, subacute and chronic thyroiditis: a novel application of the method. Eur J Endocrinol. 2012;166(3):425–32. https://doi.org/10.1530/eje-11-0736.

Frates MC, Marqusee E, Benson CB, Alexander EK. Subacute granulomatous (de Quervain) thyroiditis: grayscale and color Doppler sonographic characteristics. J Ultrasound Med. 2013;32(3):505–11. https://doi.org/10.7863/jum.2013.32.3.505.

Park SY, Kim EK, Kim MJ, Kim BM, Oh KK, Hong SW, et al. Ultrasonographic characteristics of subacute granulomatous thyroiditis. Korean J Radiol. 2006;7(4):229. https://doi.org/10.3348/kjr.2006.7.4.229.

Croce L, Gangemi D, Ancona G, Liboà F, Bendotti G, Minelli L, et al. The cytokine storm and thyroid hormone changes in COVID-19. J Endocrinol Investig. 2021;9:1–4. https://doi.org/10.1007/s40618-021-01506-7.

Wang W, Su X, Ding Y, Fan W, Zhou W, Su J, et al. Thyroid function abnormalities in COVID-19 patients. Front Endocrinol. 2020;11. https://doi.org/10.3389/fendo.2020.623792.

Wei L, Sun S, Xu C-h, Zhang J, Xu Y, Zhu H, et al. Pathology of the thyroid in severe acute respiratory syndrome. Hum Pathol. 2007;38(1):95–102. https://doi.org/10.1016/j.humpath.2006.06.011.

Tang Y, Liu J, Zhang D, Xu Z, Ji J, Wen C. Cytokine storm in COVID-19: the current evidence and treatment strategies. Front Immunol. 2020;11:1708. https://doi.org/10.3389/fimmu.2020.01708.

Wang Q, Zhang Y, Wu L, Niu S, Song C, Zhang Z, et al. Structural and functional basis of SARS-CoV-2 entry by using human ACE2. Cell. 2020;181(4):894–904. e9. https://doi.org/10.1016/j.cell.2020.03.045.

Hoffmann M, Kleine-Weber H, Schroeder S, Krüger N, Herrler T, Erichsen S, et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. 2020;181(2):271–80. e8. https://doi.org/10.1016/j.cell.2020.02.052.

Kuba K, Imai Y, Rao S, Gao H, Guo F, Guan B, et al. A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus–induced lung injury. Nat Med. 2005;11(8):875–9. https://doi.org/10.1038/nm1267.

Rotondi M, Coperchini F, Ricci G, Denegri M, Croce L, Ngnitejeu S, et al. Detection of SARS-COV-2 receptor ACE-2 mRNA in thyroid cells: a clue for COVID-19-related subacute thyroiditis. Journal of endocrinological investigation. 2020:1-6.https://doi.org/10.1007/s40618-020-01436-w

Lazartigues E, Qadir MMF, Mauvais-Jarvis F. Endocrine significance of SARS-CoV-2’s reliance on ACE2. Endocrinology. 2020;161(9):bqaa108. https://doi.org/10.1210/endocr/bqaa108.

Li W, Moore MJ, Vasilieva N, Sui J, Wong SK, Berne MA, et al. Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature. 2003;426(6965):450–4. https://doi.org/10.1038/nature02145.

Turner AJ, Tipnis SR, Guy JL, Rice GI, Hooper NM. ACEH/ACE2 is a novel mammalian metallocarboxypeptidase and a homologue of angiotensin-converting enzyme insensitive to ACE inhibitors. Can J Physiol Pharmacol. 2002;80(4):346–53. https://doi.org/10.1139/y02-021.

Li M-Y, Li L, Zhang Y, Wang X-S. Expression of the SARS-CoV-2 cell receptor gene ACE2 in a wide variety of human tissues. Infectious diseases of poverty. 2020;9:1–7. https://doi.org/10.1186/s40249-020-00662-x.

Bellastella G, Maiorino MI, Esposito K. Endocrine complications of COVID-19: what happens to the thyroid and adrenal glands? J Endocrinol Investig. 2020;43:1169–70. https://doi.org/10.1007/s40618-020-01311-8.

Chen W, Tian Y, Li Z, Zhu J, Wei T, Lei J. Potential interaction between SARS-CoV-2 and thyroid: a review. Endocrinology. 2021. https://doi.org/10.1210/endocr/bqab004.

Lazarus JH. Silent thyroiditis and subacute thyroiditis. Werner and Ingbar's The Thyroid-A Fundamental and Clinical Text. 1996:577-91.

Bindra A, Braunstein GD. Thyroiditis. Am Fam Physician. 2006;73(10):1769–76.